Published in Obes Rev on November 01, 2006
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol (2009) 10.18
Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst (2010) 2.04
Metformin: multi-faceted protection against cancer. Oncotarget (2011) 2.00
Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer (2008) 1.89
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene (2009) 1.69
Obesity and weight change in relation to breast cancer survival. Breast Cancer Res Treat (2010) 1.60
Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med (2009) 1.57
Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer (2008) 1.35
Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun Signal (2009) 1.35
Childhood obesity and environmental chemicals. Mt Sinai J Med (2011) 1.31
Metabolic syndrome and cancer. Metab Syndr Relat Disord (2009) 1.24
HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol (2008) 1.19
Ethnic differences in breast cancer survival: status and determinants. Womens Health (Lond Engl) (2011) 1.16
Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry. Breast Cancer Res Treat (2010) 1.14
Obesity in cancer survival. Annu Rev Nutr (2012) 1.13
Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy. J Womens Health (Larchmt) (2009) 1.12
Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer (2010) 1.11
Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures. Support Care Cancer (2011) 1.10
Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.08
Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. J Cancer Surviv (2012) 1.08
Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. ScientificWorldJournal (2011) 1.04
Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors. BMC Cancer (2012) 1.03
Influence of diet on metastasis and tumor dormancy. Clin Exp Metastasis (2008) 0.97
Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Breast Cancer Res (2013) 0.96
Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice. Breast Cancer Res (2011) 0.96
Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk? BMC Cancer (2013) 0.96
Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer. Mol Cancer Ther (2012) 0.94
Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res (2015) 0.92
The role of adipose-derived stem cells in breast cancer progression and metastasis. Stem Cells Int (2015) 0.90
Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J (2014) 0.89
Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancer. PLoS One (2012) 0.89
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes. Breast Cancer Res (2015) 0.85
Dietary fat alters body composition, mammary development, and cytochrome p450 induction after maternal TCDD exposure in DBA/2J mice with low-responsive aryl hydrocarbon receptors. Environ Health Perspect (2009) 0.84
Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls. J Exp Clin Cancer Res (2009) 0.84
Body mass index and serum proteomic profile in breast cancer and healthy women: a prospective study. PLoS One (2012) 0.83
Risk of advanced-stage breast cancer among older women with comorbidities. Cancer Epidemiol Biomarkers Prev (2012) 0.83
Weight Loss Intervention for Breast Cancer Survivors: A Systematic Review. Curr Breast Cancer Rep (2015) 0.82
Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation. Diabetol Metab Syndr (2011) 0.81
Breast cancer biomarkers predict weight loss after gastric bypass surgery. BMC Res Notes (2012) 0.80
IGF-Binding Protein 2 - Oncogene or Tumor Suppressor? Front Endocrinol (Lausanne) (2015) 0.79
Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients. Cancer Med (2015) 0.79
The impact of overweight and obesity on breast cancer: data from Switzerland, so far a country little affected by the current global obesity epidemic. Gland Surg (2014) 0.79
The impact of functional limitations on long-term outcomes among African-American and white women with breast cancer: a cohort study. BMJ Open (2013) 0.78
Biomarkers of the metabolic syndrome and breast cancer prognosis. Cancers (Basel) (2010) 0.78
Differences between Hispanic and non-Hispanic white women with breast cancer for clinical characteristics and their correlates. Ann Epidemiol (2013) 0.77
Excess weight gain accelerates 1-methyl-1-nitrosourea-induced mammary carcinogenesis in a rat model of premenopausal breast cancer. Cancer Prev Res (Phila) (2014) 0.77
Decreasing 25-hydroxy-vitamin D levels account for portion of the effect of increasing body mass index on breast cancer mortality. Mol Nutr Food Res (2012) 0.77
Mammographic density as a predictor of breast cancer outcome. Future Oncol (2010) 0.77
Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer. Oncotarget (2016) 0.77
The Obesity-Breast Cancer Conundrum: An Analysis of the Issues. Int J Mol Sci (2016) 0.76
Causal attributions to epidemiological risk factors and their associations to later psychological adjustment among Japanese breast cancer patients. Support Care Cancer (2008) 0.76
Study design and protocol for moving forward: a weight loss intervention trial for African-American breast cancer survivors. BMC Cancer (2015) 0.75
Associations of anthropometric measures on breast cancer risk in pre- and postmenopausal women-a case-control study. J Physiol Anthropol (2016) 0.75
The Role of Docosahexaenoic Acid (DHA) in the Control of Obesity and Metabolic Derangements in Breast Cancer. Int J Mol Sci (2016) 0.75
The health of women treated for breast cancer: A challenge in primary care. Australas Med J (2012) 0.75
Adiposity, inflammation, genetic variants and risk of post-menopausal breast cancer findings from a prospective-specimen-collection, retrospective-blinded-evaluation (PRoBE) design approach. Springerplus (2013) 0.75
Community-based participatory research to improve life quality and clinical outcomes of patients with breast cancer (DianaWeb in Umbria pilot study). BMJ Open (2016) 0.75
The effect of lipoaspirates vs. dissected abdominal fat on breast cancer cells in vitro. Eur J Med Res (2017) 0.75
STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance. Endocr Relat Cancer (2017) 0.75